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ackground & Aims: Biofeedback is reported to be as
ffective for slow transit constipation as for pelvic floor
yssynergia and no more effective than education. We
imed to test the hypothesis that biofeedback benefits
nly patients with pelvic floor dyssynergia, describe
he physiologic mechanism of treatment, and identify
redictors of success. Methods: Fifty-two patients (49
omen; average age, 35 years), all with delayed whole
ut transit, included 34 with pelvic floor dyssynergia, 12
ith slow transit only, and 6 who met only 1 of 2 criteria
or pelvic floor dyssynergia. All received 5 weekly
iofeedback sessions directed at increasing rectal pres-
ure and relaxing pelvic floor muscles during straining
lus practice defecating a balloon. Patients were re-
ested by questionnaire; symptom diary; balloon defeca-
ion; transit study at 1, 6, 12, and 24 months; and
norectal manometry at 1 and 6 months. Results: At 6
onths, greater improvements were seen in pelvic floor
yssynergia compared with slow transit only; 71% ver-
us 8% reported satisfaction (P  .001), and 76% versus
% reported >3 bowel movements per week (P < .001).
mprovements were maintained at 24 months of follow-
p. Biofeedback eliminated dyssynergia in 91% and
nabled 85% to defecate the balloon. Satisfaction was
orrelated with improved ability to defecate the balloon
  .73; P < .001), reductions in dyssynergia (  .69;
< .001), and increased rectal pressure during strain-
ng (  .36; P < .01). Success was predicted by pelvic
oor dyssynergia, milder constipation, and less frequent
bdominal pain at baseline. Conclusions: Biofeedback is
n effective treatment for pelvic floor dyssynergia but
ot slow transit constipation.
onstipation is a symptom that affects 12%–19% of
adults in the United States.1 Several pathophysio-
ogic mechanisms are recognized that may cause consti-
ation, including megacolon or megarectum (dilated,
tonic bowel) and drug side effects. However, the most
ommonly recognized types of constipation are slow
ransit constipation and outlet dysfunction.2
Slow transit constipation is defined as delayed transit
hroughout the colon and is believed to result fromeduced numbers of high-amplitude propagating con-
ractions3,4 associated with decreased numbers of inter-
titial cells of Cajal.5,6 Diagnosis is based on transit
tudies showing abnormally prolonged transit of ra-
iopaque markers or radioisotopes through the colon.7,8
Outlet dysfunction–type constipation refers to diffi-
ulty evacuating the rectum. Preston and Lennard-Jones9
ere the first to describe this type of constipation; they
howed that a subgroup of patients with constipation
ailed to relax the pelvic floor muscles during defecation
nd instead paradoxically contracted these muscles. Sub-
equent investigators supported their observation,10 and
iofeedback techniques were developed to teach patients
o evacuate the rectum by relaxing the pelvic floor mus-
les.11,12 However, Duthie and Bartolo13 found that up to
0% of constipated patients who exhibit paradoxical
ontraction of the pelvic floor muscles in the gastroen-
erology clinic may show normal pelvic floor relaxation
uring defecation at home, and others have noted that a
ignificant proportion of asymptomatic people show par-
doxical contraction of the pelvic floor when tested in the
linic. Rao et al14 showed that inadequate intrarectal
ressure during attempts at defecation may also explain
ailure to evacuate the rectum. These observations have
ed to controversy over whether pelvic floor dyssynergia
s a distinct mechanism for constipation.
Biofeedback training to teach relaxation of the pelvic
oor was reported to be effective in a number of tri-
ls,12,15,16 with the median response rate approximately
7%.12 However, there have been no randomized con-
rolled trials to confirm efficacy in adults. The St Mark’s
roup17–19 reported that biofeedback was equally effec-
ive in patients with slow transit constipation and those
ith outlet dysfunction characterized by paradoxical con-
Abbreviations used in this paper: ANCOVA, analysis of covariance;
IX, mixed; PFD, pelvic floor dyssynergia with slow transit; STO, slow
ransit only.































































































July 2005 BIOFEEDBACK FOR PELVIC FLOOR DYSSYNERGIA 87raction of the pelvic floor and that biofeedback training
esulted in acceleration of whole gut transit time in
atients with slow transit constipation. This claim of
qual efficacy in slow transit constipation and outlet
ysfunction constipation was supported by an indepen-
ent research group.20 The St Mark’s group also reported
hat biofeedback was no more effective than education
nd training performed with verbal feedback but without
nstruments to assist patients in learning to relax the
elvic floor.17 These 2 observations, that biofeedback to
each relaxation of the pelvic floor is as effective in
atients who do not demonstrate pelvic floor dysfunction
s a cause of their constipation as it is in patients with
elvic floor dyssynergia and that visual feedback is no
ore effective than education, challenge claims that
iofeedback training makes a specific contribution to the
reatment of constipation that is distinct from education
r psychotherapy.
The primary aim of this study was to determine
hether biofeedback to teach relaxation of the pelvic
oor muscles benefits only patients with outlet dysfunc-
ion–type constipation versus whether, as claimed by the
t Mark’s group, it improves constipation equally well in
atients with slow transit constipation who do not have
utlet dysfunction. Secondary aims were to determine
hether physiologic parameters identify the mechanism
f biofeedback training effects (ie, whether clinical ben-
fits of biofeedback are related to changes in pelvic floor
hysiology or are nonspecific) and to determine whether
hysiologic parameters or clinical symptoms recorded at
aseline identify the patients who are most likely to
espond to biofeedback training.
Materials and Methods
Patients
Seventy-five consecutive patients referred to the gastro-
nterology clinic of the Division of Gastrointestinal Rehabilita-
ion of the University of Verona at Valeggio s/M Hospital,
zienda Ospedaliera di Verona, for refractory, long-standing (at
east 12 months) constipation between June 1997 and January
001 were screened for the study. All patients were evaluated by
istory, complete medical examination, biochemical studies to
xclude secondary causes of constipation such as hypothyroidism
nd drug side effects, and a barium enema study to identify those
ith megacolon or megarectum. All patients were then enrolled
nto a 1-month run-in phase to confirm that they met inclusion
riteria (see following text). The study was conducted in compli-
nce with the Declaration of Helsinki.
Run-in Period
For 30 days, all patients were treated with conservative
edical management consisting of 30 g/day of fiber supple- aentation. They were allowed to take laxatives or enemas
uring this run-in period. All patients were asked to keep a
ymptom diary in which they recorded (1) laxative and/or
nema use, (2) number of bowel movements, (3) straining at
tool, (4) experience of severe pain, and (5) experience of severe
loating. Pain and bloating were defined as severe if they were
ntense enough to interfere with usual daily activities. At the
nd of the 1-month run-in period, patients’ diaries were re-
iewed. Five patients were excluded (2 for not keeping the
iary and 3 for almost-daily consumption of laxatives). The
emaining 70 patients underwent a Sitzmark test21 of whole
ut transit while abstaining from laxatives and enemas (see
ollowing text).
Inclusion/Exclusion Criteria
To be included, patients had to (1) report 3 bowel
ovements per week by history, (2) fail a test of a high-fiber
iet (at least 30 g/day for 30 days during the run-in period),
nd (3) have an abnormally delayed whole gut transit study
efined as 5 of 20 Sitzmarks remaining in the colon 5 days
fter ingestion. Patients were enrolled regardless of whether
hey reported anorectal symptoms suggestive of outlet dys-
unction. Patients were excluded if they had (1) previous
bdominal surgery except for appendectomy; (2) megacolon,
egarectum, or hypothyroidism; or (3) resolution of symp-
oms on conservative medical management (fiber supplemen-
ation).
Fifty-two patients who satisfied inclusion and exclusion
riteria were invited to participate in a behavioral therapy trial,
nd all agreed and signed an informed consent statement.
hese 52 patients with slow transit constipation included 49
omen and 3 men with an average age of 34.9  10.2 years
mean  SD; range, 23–63 years).
Study Design
Figure 1 shows the study design. Patients who satisfied
nclusion/exclusion criteria at the end of the run-in phase were
valuated by anorectal manometry and balloon defecation tests
nd were classified as either slow transit only (STO), pelvic
oor dyssynergia with slow transit (PFD), or mixed (MIX).
he STO group included patients who retained 5 Sitzmarks
days after ingesting 20 of them and who satisfied neither of
he 2 criteria for PFD. The PFD group included patients with
low transit constipation (5 of 20 Sitzmarks remaining 5
ays after ingestion) who met both of 2 criteria: paradoxical
ontraction or failure to relax the pelvic floor muscles during
ttempts to defecate and inability to evacuate a 50-mL water-
lled balloon within 5 minutes. The MIX group included
atients with slow transit constipation who satisfied one but
ot both of the criteria for PFD. All patients (regardless of
iagnostic group assignment) received 5 sessions of biofeed-
ack training to teach relaxation of the pelvic floor during
efecation and were then followed up by repeat manometry,
alloon defecation, Sitzmark study of transit, 1-month symp-
om diary, and ratings of satisfaction with treatment outcome















































88 CHIARIONI ET AL GASTROENTEROLOGY Vol. 129, No. 1ion of biofeedback training. With few exceptions (noted in
igure 1), the PFD group returned to the clinic to provide
atisfaction ratings and kept a 1-month symptom diary at 12
onths and 24 months of follow-up but were not asked to
epeat the anorectal manometry test at 12 months and 24
onths. When any patient declined to return to the clinic for
ollow-up or to keep 1-month symptom diaries at 12 months
r 24 months, follow-up data on satisfaction with treatment
ere collected by telephone.
Sitzmark Study of Whole Gut Transit Time
The Hinton technique21 was used to measure whole
ut transit time. Patients ingested a gelatin capsule containing
0 radiopaque soft rubber markers (Sitzmarks; Konsyl Phar-
aceuticals, Fort Worth, TX), and a single abdominal radio-
raph was taken on the fifth day. Patients were asked to
onsume 30 g/day of fiber supplement during the week pre-
eding and the week of the Sitzmark study. The results of the
tudy were said to be abnormal if 5 of 20 markers remained
n the colon at day 5. Rectal stasis was defined by the patient
etaining more than 10 markers at day 5, with more than 80%
f them located in the rectosigmoid area.
Balloon Defecation Test
A flexible plastic catheter (10-cm long; OD, 3 mm)
ith a latex balloon made from a condom (SSL Healthcare
talia, Bologna, Italy) on its tip was lubricated and inserted
Figure 1.nto the rectum. This balloon was 5 cm long by 3 cm wide ahen deflated and 5 cm long by 3.5 cm in diameter (approx-
mately cylindrical in shape) when inflated with 50 mL of
ater. After insertion, the balloon was filled with 50 mL of
ater at room temperature, and the patient was instructed to
it on a commode chair in a room by themselves and to pass the
alloon. Up to 5 minutes was allowed for defecation, and any
atient who was unable to pass the balloon was judged to have
n abnormal balloon defecation test result.
Anorectal Manometry
The manometry catheter (model R6B; Mui Scientific,
issisauga, Ontario, Canada) had a latex balloon on its tip that
ould be distended with air via a handheld syringe, and it had
perfusion ports spaced 1 cm apart beginning 2 cm below the
alloon to measure pressures. The inner diameter of each of the
perfusion catheters was 0.8 mm, and they were perfused with
egassed water at a rate of 0.5 mL/min by a low-compliance
ump (Arndorfer Medical Specialties, Greendale, WI). The
uter diameter of the catheter was 4.5 mm. Pressures were
ecorded and displayed using a model GR 800 polygraph
Aspen Medical, Dingwall, Scotland). Pressure recordings were
nalyzed manually.
With the patient in the left lateral position, the manometry
athether was lubricated and inserted into the rectum. It was
hen pulled back in 0.5-cm steps, and pressures were recorded
t each position while the patient was instructed to relax. The
eak pressure (averaged across all 4 perfusion ports) defined




























































































July 2005 BIOFEEDBACK FOR PELVIC FLOOR DYSSYNERGIA 89ositioned in the high-pressure zone of the anal canal, and the
ectal balloon was distended with varying volumes of air (50,
0, 30, 20, 15, 10, and 5 mL) to determine the smallest
olume of distention that elicited a rectoanal inhibitory reflex
defined as the reflex decrease in anal canal pressure that is
licited by rectal distention). Next, the rectal balloon was
nflated in 20-mL steps up to 500 mL to assess the threshold
or the sensation of urge to defecate and the maximum toler-
ble volume. Compliance was defined as the rectal balloon
ressure at 100-mL distention. The peak pressure in the rec-
um during straining to defecate was recorded and defined as
training pressure.22 Finally, the patient was asked to strain to
ass the rectal balloon and was considered dyssynergic if anal
anal pressure during straining demonstrated either a paradox-
cal contraction or a failure to decrease (relax). A phosphate
nema was administered approximately 2 hours before the
norectal manometry and balloon defecation tests.
Definition of Pelvic Floor Dyssynergia
Patients were categorized as PFD if they satisfied both
f 2 criteria: (1) dyssynergia on manometry and (2) inability to
efecate a 50-mL water-filled balloon in 5 minutes. Both
riteria were met by 34 patients who were classified as PFD.
welve patients fulfilled neither of these criteria and were
lassified as STO. Six patients were discordant; 2 demonstrated
yssynergia on manometry but were able to defecate the
alloon, and 4 could not defecate the balloon but had normal
anometry. These 6 discordant patients were classified as MIX
nd were analyzed separately.
Biofeedback Training
All 52 patients meeting inclusion criteria were told
hat their constipation could be related to a defecation disorder
nd that improving the defecation process might help them.
ll of them underwent 5 weekly biofeedback training sessions
hat lasted 30–45 minutes. All biofeedback training was done
y one of the investigators (G.C.), who was not aware of the
esults of the manometry and balloon expulsion tests.
Biofeedback training consisted of 3 phases. In the first
hase, patients were taught to strain more effectively and to
oordinate expulsion efforts with their breathing. This was
sually accomplished in the first session. In the second phase of
raining, a portable, battery-operated electromyographic in-
trument (Myotron-120; Enting Instruments & Systems,
orst, The Netherlands) was used to teach the patient to relax
he sphincter during straining. The anal plug had a bulb on its
nd to hold it in position, and it had 3 longitudinally oriented
etal plates on its surface to record electromyography from the
nal canal. The electromyographic signal was averaged and
hen displayed on a monitor in microvolts. Patients watched
he display while contracting and relaxing the anal sphincter.
hey were told that higher numbers were related to closure of
he sphincter and smaller numbers were associated with open-
ng the sphincter and that the lower the numbers were during
training, the more effective defecation would become. jIn the third phase of training, patients practiced defecating
n air-filled balloon attached to a catheter. With the patient
aying on his or her left side, the catheter was placed into the
ectum and inflated with 50 mL of air. The inflated balloon
as gently pulled out of the rectum by the investigator while
he patient attempted to avoid contracting the sphincter. On
uccessive trials, the amount of assistance from the therapist
amount of traction on the catheter) was gradually decreased as
he patient learned to strain effectively to expel the inflated
allon.
All 3 phases of training had to be accomplished in 5
essions, with at least one session of balloon feedback. At the
nd of therapy, all patients were told that their pushing effort
ad improved and that they had to be followed up to monitor
he effects of this training on their symptoms. All patients
ere asked to continue on a high-fiber diet and to avoid using
axatives as much as possible.
Follow-up
Anorectal manometry, the balloon expulsion test, and
he Sitzmark transit study were repeated 1 and 6 months after
ompletion of therapy. All patients were also asked to report to
he clinic 12 months and again 24 months after the end of
herapy, and the balloon expulsion test and Sitzmark transit
tudy were repeated. (However, for the most part, only re-
ponders returned for 12-month and 24-month follow-up.)
ne month before the clinic appointment, patients were re-
inded by telephone to keep a 30-day symptom diary in
hich they reported the same parameters as during the run-in
eriod.
Clinical Outcome Measures
The primary outcome measure was the patients’ rating
f their overall improvement. All patients were asked, either at
heir follow-up clinic visit or by telephone if they did not
eturn to the clinic, to rate their overall improvement by
esponding to the following question: “How would you grade
our symptom improvement: none (1), mild (2), fair (3), or
ajor (4).” In addition, patients were asked to keep a 30-day
ymptom diary before each follow-up visit in which they
ecorded each day the number of bowel movements, occurrence
f excessive straining with bowel movements, use of laxatives,
ccurrence of pain, and occurrence of bloating. The average
umber of these events per week was used in data analysis.
Physiologic Outcome Measures
Whole gut transit time and ability to defecate a 50-mL
ater-filled balloon were evaluated at baseline and at each
ollow-up interval. Anorectal manometry parameters were re-
orded at baseline, 1-month follow-up, and 6-month follow-up
nd included the following: resting pressure in the anal canal,
ectoanal inhibitory reflex, urge threshold, maximum tolerable
olume, compliance, rectal pressure during straining, and
resence of dyssynergia. Physiologic parameters (including






















































































90 CHIARIONI ET AL GASTROENTEROLOGY Vol. 129, No. 1y one investigator who was blind to the results of the Sitz-
ark study and the balloon defecation test.
Statistical Analysis
In all analyses of treatment efficacy, all 52 patients who
et inclusion criteria and entered the trial were retained in the
nalyses, and all 3 groups were included. However, follow-up
ests (paired comparisons) compared only the STO group with
he PFD group because this provided the most unambiguous
est of the hypotheses. As shown in Figure 1, there were few
issing data for the primary outcome measure (improvement
atings); these were dealt with by carrying forward the last
vailable observation.
The primary outcome variable was an ordinal scale rating
anging from 1 to 4. Because this variable was not continuous
r normally distributed, the primary test of the hypothesis was
Kruskall–Wallis test comparing STO, MIX, and PFD at each
ollow-up interval. Follow-up paired comparisons between the
TO and PFD groups used the Mann–Whitney U test. Aver-
ge ratings were also computed for graphical representation.
All continuous variables were analyzed by repeated-mea-
ures analysis of covariance (ANCOVA) using the SPSS general
inear models program,23 followed by t tests comparing the
TO group with the PFD group at each time point. Age was
ntered as a covariate in these analyses because age differences
etween the PFD and STO groups approached significance (P
.053). Dichotomous variables (balloon defecation and pres-
nce of dyssynergia) were analyzed by separate 2 tests com-
aring STO with PFD at baseline and at each follow-up
nterval. An  level of .05 was used for all statistical tests.
One of our secondary aims was to determine whether
iofeedback treatment effects were related to changes in phys-
ology (the goal of biofeedback training) or were nonspecific.
o assess this, we pooled all 52 patients and calculated changes
n physiologic parameters from baseline to the 1-month and
-month follow-up assessments and then computed the Spear-
an nonparametric correlations between these change scores
nd patient ratings of satisfaction with treatment at 1-month
nd 6-month follow-up. We also used ordinal regression anal-
sis to determine which of the variables identified by signifi-
ant univariate correlations made significant independent con-
ributions to the prediction of successful biofeedback training
fter adjusting for the intercorrelations among these variables.
Another secondary aim was to determine whether there were
aseline physiologic or clinical characteristics that could iden-
ify which patients were most likely to receive a clinical benefit
rom biofeedback training. For these analyses, all 52 patients
ere pooled and the nonparametric Spearman correlation be-
ween the treatment satisfaction rating at 6 months and all
hysiologic and clinical characteristics recorded at baseline was
omputed. We also used ordinal regression analysis to deter-
ine which of the baseline variables identified by significant
nivariate correlations made significant independent contribu-
ions to the prediction of successful biofeedback training after
djusting for the intercorrelations among these variables. “Results
Demographics
The 12 patients in the STO group included 2
en, the 34 patients in the PFD group included one
an, and the 6 patients in the MIX group included no
en. The average (mean  SD) age of patients in the
TO group was 39.6  11.8 years, compared with 36.7
10.3 years for patients in the MIX group and 32.9 
.3 years for patients in the PFD group. Differences in
ge between the STO and PFD groups approached sig-
ificance (t[44]  1.99; P  .053). Although no exclu-
ion criteria on the basis of age, race, or other personal
actors were used, all patients were Italians of European
escent.
Clinical Characteristics
All patients reported frequent use of laxatives or
nemas, and all reported that they had needed to grad-
ally increase their use of laxatives to achieve defecation.
heir average duration of constipation was 14 years
range, 2–40 years). Digital facilitation of defecation was
olunteered by 8 patients, of whom 7 were unable to
efecate a 50-mL water-filled balloon.
Patients Lost to Follow-up
As shown in Figure 1, all patients attended the
-month follow-up, but 2 patients (one in the STO
roup and one in the MIX group) did not return for the
-month follow-up. Both were nonresponders; when con-
acted by telephone at 6 months, one was consulting a
ocal surgeon for colectomy (STO group) and the other
ad been in an automobile accident and sustained a
elvic fracture (MIX group). She was lost to subsequent
ollow-up. The same 2 patients plus one additional STO
atient failed to return for the 12-month follow-up. At
4 months, one patient in the STO group could not be
ontacted and 2 patients had undergone a colectomy. At
4 months, 2 patients in the MIX group could not be
ontacted. In the PFD group, one patient was lost to
ollow-up and one patient had undergone a colectomy by
he 24-month follow-up.
Satisfaction With Treatment
Figure 2 shows average satisfaction ratings at each
ollow-up interval. Patients in the PFD group rated their
atisfaction with treatment significantly (P  .001)
igher than patients in the STO group at each follow-up
nterval. Seventy-one percent of patients in the PFD
roup rated their satisfaction with treatment as “fair” or



















































July 2005 BIOFEEDBACK FOR PELVIC FLOOR DYSSYNERGIA 91atients in the STO group and 50% of patients in the
IX group (P  .001).
Stool Frequency
Figure 3 shows the average frequency of bowel
ovements at baseline and each follow-up interval. Re-
eated-measures ANCOVA showed a significant inter-
ction between groups and time periods (Greenhouse–
eisser corrected F[3.89, 93.32]  7.23; P  .001).
aired comparisons showed that there was no difference
etween the groups at baseline; however, at each subse-
uent follow-up interval, patients in the PFD group had
ignificantly (P  .001) more bowel movements than
atients in the STO group. At 6-month follow-up, 76%
f patients in the PFD group were having 3 bowel
ovements per week compared with 8% of patients in
he STO group (P  .001); this difference persisted at
2-month follow-up (82% vs 8%) and 24-month fol-
ow-up (79% vs 8%) (P  .001 for each comparison). At
aseline, 12% of patients in the PFD group and none of
he patients in the STO group reported having 3 bowel
ovements per week.
igure 2. Satisfaction ratings (mean  SE). Open bars, STO group;
ray bars, MIX group; black bars, PFD group. 1, none; 2, mild; 3, fair;
, major satisfaction with treatment. All comparisons are significant
t P  .001.
igure 3. Bowel movements per week at baseline and each follow-up
nterval (mean  SE). Open bars, STO group; gray bars, MIX group;
lack bars, PFD group. For each follow-up interval, STO versus PFD is
ignificant at P  .001. bLaxative Use
Figure 4 shows the average frequency of using
axatives at baseline and each follow-up interval. Repeat-
d-measures ANCOVA showed that the interaction be-
ween groups and time period approached signficance
Greenhouse–Geisser F[4.51, 108.19]  2.65; P 
032). Paired comparisons showed that the STO group
as signficantly different from the PFD group at all
ollow-up intervals (P  .01 in each case), but the groups
ere not different at baseline. None of the patients in the
rial were able to stop using laxatives altogether.
Straining Frequency
Figure 5 shows the average frequency of straining
ith bowel movements at baseline and each follow-up
nterval. Repeated-measures ANCOVA showed a signif-
cant interaction between groups and time period
Greenhouse–Geisser F[2.98, 71.59]  4.09; P  .017).
lthough Figure 5 suggests that patients in the PFD
roup strained less than patients in the STO group
uring follow-up, these differences were not statistically
ignificant (P  .05 in each case). The significant inter-
igure 4. Average number of laxatives per week at baseline and each
ollow-up interval (mean  SE). Open bars, STO group; gray bars, MIX
roup; black bars, PFD group. For each follow-up interval, STO versus
FD is significant at P  .001.
igure 5. Straining episodes per week at baseline and each follow-up
nterval (mean  SE). The PFD group showed a greater reduction from

































































92 CHIARIONI ET AL GASTROENTEROLOGY Vol. 129, No. 1ction is explained by the fact that the PFD group
howed a greater reduction in straining from baseline
han did the STO group.
Bloating Frequency
Figure 6 shows the average number of days per
eek with bloating at baseline and each follow-up inter-
al. Repeated-measures ANCOVA showed a significant
nteraction between groups and time period (Green-
ouse–Geisser F[3.05, 73.30]  5.22; P  .002). Paired
omparisons showed that the groups were not different at
aseline; however, at the 1-, 6-, 12-, and 24-month
ollow-up intervals, patients in the PFD group had sig-
ificantly (P  .015) less bloating than patients in the
TO group.
Pain Frequency
Repeated-measures ANCOVA did not show a
ignificant interaction between groups and time period
Geisser–Greenhouse corrected F[3.81, 91.56]  0.29; P
.875). Paired comparisons showed that patients in the
FD group reported less pain than patients in the STO
roup at all follow-up intervals (P  .05 in each case),
ut the groups were not different at baseline (data not
hown).
Whole Gut Transit Time
Figure 7 shows the average number of Sitz-
arks remaining in the colon on day 5 at baseline and
t each follow-up interval. Repeated-measures AN-
OVA showed a significant interaction between
roups and time period (Greenhouse–Geisser F[2.32,
5.70]  8.40; P  .001). Paired comparisons showed
hat patients in the PFD group had fewer Sitzmarks
emaining on day 5 than patients in the STO group at
very follow-up interval (P  .001 in each case).
igure 6. Bloating episodes per week at baseline and each follow-up
nterval (mean  SE). Open bars, STO group; gray bars, MIX group;
lack bars, PFD group. For follow-up intervals 1, 6, and 12 months,
TO versus PFD is significant at P  .01.atients in the PFD group also had fewer Sitzmarks demaining (ie, faster transit time) than patients in the
TO group at baseline (P  .015), but the differences
etween groups were significantly larger following
iofeedback training.
When the Sitzmark test data were interpreted in
erms of the proportion who had an abnormal transit
est result (defined as 5 Sitzmarks remaining in the
owel at day 5), there was no difference between the
roups at baseline (100% in all 3 groups by defini-
ion); however, at all follow-up intervals, transit was
bnormally delayed in a significantly smaller propor-
ion of patients in the PFD group compared with
atients in the STO group: 41% versus 92% at
-month follow-up and 35% versus 92% at 6-, 12-,
nd 24-month follow-up.
Rectal stasis, defined as at least 10 of 20 Sitzmarks
emaining in the bowel on day 5 with at least 80% of
hem in the sigmoid colon or rectum, was present in
5% (12 patients) with PFD, 17% (one patient) in the
IX group, and none of the STO group at baseline (P
.046).
Balloon Defecation Test
Figure 8 shows the proportion of patients who
ere able to defecate a 50-mL water-filled balloon within
minutes in each group at baseline and at each follow-up
nterval. By definition, none of the patients in the PFD
roup and all of the patients in the STO group could
efecate the balloon at baseline. Following biofeedback
raining, 82%–85% of the PFD group could do so.
Dyssynergia
By definition, 100% of patients in the PFD group
emonstrated dyssynergia at baseline and none of the
atients in the STO group were dyssynergic. Following
iofeedback training, the proportion of patients in the
igure 7. Number of Sitzmarks remaining on day 5 at baseline and
ach follow-up interval (mean  SE). Open bars, STO group; gray bars,
IX group; black bars, PFD group. For each follow-up interval, STO
ersus PFD is significant at P  .001. Five or more markers remaining

























































July 2005 BIOFEEDBACK FOR PELVIC FLOOR DYSSYNERGIA 93FD group who were dyssynergic decreased from 100%
o 9% at 6 months (Table 1). For the MIX group, 33%
ere dyssynergic at baseline; this decreased to 17% by 6
onths after biofeedback training.
Mechanism of Biofeedback Training
As predicted, satisfaction ratings were robustly
orrelated with reductions in dyssynergia at 1-month
ollow-up (  0.69; P  .001) and 6-month fol-
ow-up (  0.70; P  .001) and with improvements
n ability to defecate the water-filled balloon at 1-month
ollow-up (  .72; P  .001) and 6-month follow-up (
.73; P  .001). Satisfaction ratings were also corre-
ated with increased straining pressure at 1-month fol-
ow-up (  .36; P  .01) and 6-month follow-up ( 
36; P  .01). The only other change in pelvic floor
hysiology that was correlated with satisfaction ratings
as maximum tolerable volume; at 1-month follow-up,
ecreases in maximum tolerable volume correlated with
atisfaction at a  of 0.28 (P  .05). This correlation
as not significant at 6-month follow-up.
igure 8. Percent of patients in each group who succeeded in defe-
ating a 50-mL water-filled balloon within 5 minutes. Open bars, STO
roup; gray bars, MIX group; black bars, PFD group.









Mean SD Mean SD Mean S
TO group
Baseline 60.67 12.05 17.50 4.52 108.33 35
1-month follow-up 61.33 13.51 17.50 4.52 75.00a 26
6-month follow-up 61.82 12.87 16.36 5.05 72.73a 26
IX group
Baseline 70.33 14.73 13.33 5.16 108.33 20
1-month follow-up 70.17 14.58 15.00 5.48 58.33 20
6-month follow-up 73.60 10.24 14.00 5.48 50.00
FD group
Baseline 66.06 12.28 13.82b 5.51 100.00 34
1-month follow-up 66.21 11.54 13.82b 4.93 51.47a,b 8
6-month follow-up 66.41 12.10 13.53 4.85 51.47a,b 8
P  .05 compared with baseline for same group (within subjects).
P  .01 compared with STO group for same time point (between groups).Table 1 shows physiologic data in each group at
aseline and each follow-up interval. Baseline differences
etween the PFD group and the STO group were found
or dyssynergia (present in all patients in the PFD group
nd none of the patients in the STO group by definition)
nd rectoanal inhibitory reflex threshold (lower in the
FD group than in the STO group). However, anorectal
anometry identified no other differences between the
TO group and the PFD group at baseline.
Following biofeedback training, patients in both the
TO group and the PFD group showed significant de-
reases in urge threshold, but the reductions were greater
n the PFD group. Following biofeedback training, the
FD group showed significant decreases in dyssynergia
nd significant increases in rectal pressure during strain-
ng, whereas the STO group showed no significant
hange in these parameters. The PFD group also showed
ignificant reductions in maximum tolerable volume
rom baseline to follow-up, but patients in the STO
roup did not change their maximum tolerable volume.
Physiologic Predictors of Successful
Biofeedback Training
Table 2 shows the correlations between satisfac-
ion ratings at all follow-up intervals and all physiologic
ariables measured at baseline. Successful biofeedback
raining was predicted by all variables that reflect the
resence of pelvic floor dyssynergia, including dyssyner-
ia at baseline, inability to defecate a 50-mL water-filled
alloon, and rectal stasis. Satisfaction with biofeedback
raining was negatively correlated with the number of
itzmarks remaining in the bowel on day 5 during
aseline, suggesting that milder delays in whole gut
ransit were associated with better outcomes from










(%)Mean SD Mean SD Mean SD
279.17 65.57 11.92 3.03 45.92 12.92 0
258.22 55.73 12.17 2.92 50.67 6.41 0
254.55 56.81 12.45 3.05 51.91 6.46 0
283.33 40.83 12.67 3.08 33.00 21.33 33
241.67a 37.64 12.33 2.81 51.17 13.45 17
230.00a,b 27.39 12.00 2.91 52.00 17.07 17
270.59 66.42 13.06 2.99 36.71 14.64 100b
219.12a,b 38.95 13.53 2.80 49.53a 10.27 9a
































































94 CHIARIONI ET AL GASTROENTEROLOGY Vol. 129, No. 1ompliance was associated with the success of biofeed-
ack training; greater compliance was associated (at the
 .05 level) with better outcomes. To adjust for
ntercorrelations among the physiologic predictor vari-
bles in Table 2, an ordinal regression analysis was
erformed that included all the baseline variables in
able 2 for which the univariate correlations were sta-
istically significant. The Nagelkerke R2 value was 0.646
P  .001), and the significant independent predictors
ere number of Sitzmarks remaining in the colon after 5
ays (P  .001), stasis in the rectum (P  .011), and
alloon defecation (P  .024).
Clinical Predictors of Successful
Biofeedback Training
Table 2 shows the correlations between satisfac-
ion ratings and clinical variables measured at baseline.
ignificant correlations were found, which showed that
ore frequent bowel movements during baseline and
aking laxatives less often were predictive of greater
uccess from biofeedback training. More frequent pain
pisodes during baseline were associated with a poorer
esponse to biofeedback training. An ordinal regression
nalysis, which adjusts for the intercorrelations among
he predictor variables, showed that the Nagelkerke R2
alue was 0.314 (P  .001), and the significant inde-






No. of Sitzmarks 0.56b
Resting anal canal pressure 0.25
Rectoanal inhibitory reflex threshold 0.12
Urge threshold 0.15
Maximum tolerable volume 0.03
Compliance 0.29a







OTE. The correlations between satisfaction ratings and clinical varia
hich showed that more frequent bowel movements during baseline
iofeedback training. More frequent pain episodes during baseline w
egression analysis, which adjusts for the intercorrelations among th
.001), and the significant independent predictors were number of w
P  .013).
P  .05.
P  .01.endent predictors were number of weekly laxative doses daken (P  .004) and number of weekly pain episodes (P
.013).
Discussion
Effectiveness of Biofeedback Training in
Slow Transit Constipation
This study shows that, in contrast to recently
eported views, biofeedback is more effective for the
reatment of outlet dysfunction–type constipation than it
s for the treatment of slow transit constipation. Seventy-
ne percent of patients with PFD reported “fair” or
major” satisfaction with the degree of improvement in
heir symptoms of constipation following biofeedback
raining compared with only 8% (one patient) in the
TO group and 50% of the MIX group. These subjective
eports of improvement were supported by symptom
iary data showing that patients in the PFD group
xperienced greater improvements than patients in the
TO group in stool frequency (Figure 3), laxative use
Figure 4), straining (Figure 5), and bloating (Figure 6).
atients in the PFD group were also found to show
reater improvements in transit time (Figure 7) and the
ccurrence of dyssynergic patterns on straining to defe-
ate.
The MIX group included 6 patients who could not be
ining
Follow-up
















easured at baseline are shown. Significant correlations were found,
taking laxatives less often were predictive of greater success from
sociated with a poorer response to biofeedback training. An ordinal
dictor variables, showed that the Nagelkerke R2 value was 0.314 (P




































































































July 2005 BIOFEEDBACK FOR PELVIC FLOOR DYSSYNERGIA 95ecause they met only one of the 2 criteria for this group.
owever, as shown in Figures 2–8, they were more
imilar to the PFD group than to the STO group; they
howed improvements in satisfaction ratings, stool fre-
uency, laxative use, straining, bloating, transit time,
nd ability to defecate a water-filled balloon that were
omparable to patients in the PFD group. Based on these
imilarities, it is likely that patients who show either
nability to defecate a 50-mL water-filled balloon or
aradoxical contraction of the pelvic floor on manometry
ould benefit from biofeedback training and should be
ffered this treatment.
These data also provide an explanation for the differ-
nces between our conclusions and those of the St Mark’s
roup18,19 and Wang et al.20 These other investigators
efined slow transit constipation exclusively by the Sitz-
ark whole gut transit study and diagnosed outlet dys-
unction in any patient who demonstrated paradoxical
ontraction of the pelvic floor or failure to relax during
training to defecate; these 2 diagnostic classifications (ie,
hether the patient had slow transit and whether the
atient had pelvic floor dyssynergia) were made indepen-
ently of each other. In designing our study, we initially
ade the same assumption, that is, that these 2 diag-
ostic classifications could be made independently of
ach other. We therefore enrolled only patients who had
bnormal whole gut transit studies (5 of 20 Sitzmarks
emaining at day 5), and we further classified the same
atients as having or not having pelvic floor dyssynergia
ased on both (1) an anorectal manometry study result
emonstrating dyssynergia and (2) a balloon defecation
est result demonstrating inability to defecate a 50-mL
ater-filled balloon. However, our data suggest that this
ssumption was incorrect and that patients with delayed
hole gut transit plus pelvic floor dyssynergia did not
ave true slow transit constipation despite an abnormal
itzmark study result. This is shown by the fact that
5% of patients with pelvic floor dyssynergia plus ab-
ormally delayed Sitzmark studies normalized their tran-
it times when they were treated with biofeedback,
hereas only 22% of patients with isolated slow transit
ormalized their Sitzmark studies following biofeedback
raining. This suggests that pelvic floor dyssynergia was
he cause of the delayed transit and that the Sitzmark
tudy cannot be interpreted as a diagnostic marker for
low transit constipation in patients who have pelvic
oor dyssynergia.
The mechanism by which pelvic floor dyssynergia
auses delayed whole gut transit was not definitively
dentified in our study. One possibility is that distention
f the rectum with stool causes a reflex inhibition of
olonic motility, as has been suggested by Mollen et al.24 ghere is evidence that distention of the rectum causes a
eflex inhibition of gastric emptying,25 so reflex inhibi-
ion of colon motility is plausible. An alternative expla-
ation is a simple stopper effect; if the only outlet
vailable to the colon is obstructed, fecal material will
ave to back up. This last possibility is consistent with
he observation that 35% of patients in the PFD group
emonstrated rectal stasis (at least 10 of 20 Sitzmarks
etained and at least 80% of these in the sigmoid colon
r rectum) compared with none of the patients with
ectal stasis in the STO group. However, the fact that
5% of patients in the PFD group did not meet criteria
or rectal stasis lends weight to the hypothesis that reflex
nhibition of pancolonic motility may be responsible for
elayed transit in patients with PFD. To answer this
uestion more definitively, studies are needed in which
roximal colon motility is measured during prolonged
bstruction of defecation or prolonged distention of the
ectum. Such studies could provide new insights into the




There has also been controversy about the long-
erm benefits of biofeedback training for the treatment of
utlet dysfunction–type constipation. Some have re-
orted good maintenance of biofeedback effects at fol-
ow-up 1 year26 or 2 years18 following biofeedback tain-
ng, whereas others have described nearly a complete
egression to baseline levels of symptoms by 1 year.27
attaglia et al28 divided their patients into slow transit
nd outlet dysfunction types of constipation and reported
ood maintenance at 2 years for the outlet dysfunction
roup but not for the slow transit group. Our data
upport the findings of Battaglia et al; we observed
xcellent retention of treatment gains in the PFD group
Figures 2–6), with 71% reporting “fair” or “major”
mprovement and 65% having normal whole gut transit
imes at 24-month follow-up.
Mechanism of Biofeedback Training
Biofeedback training is designed to teach patients
o relax the pelvic floor (rather than paradoxically con-
racting it) while straining to defecate. The changes in
hysiologic measures from baseline to 1-month fol-
ow-up and 6-month follow-up suggest that these objec-
ives were achieved. When all subjects were pooled and
orrelations were computed between satisfaction with
reatment and changes in physiologic parameters, greater
atisfaction was associated with elimination of dyssyner-
























































































96 CHIARIONI ET AL GASTROENTEROLOGY Vol. 129, No. 1mproved ability to defecate a 50-mL water-filled balloon
  0.72 at 1 month;   0.73 at 6 months), and
ncreases in the pressure measured in the rectum when
atients strained to defecate (  0.36 at 1 month;  
.36 at 6 months). We also observed that greater satis-
action with biofeedback treatment was associated with
mprovements in transit time, but this may be an arti-
act. As already noted, 65% of patients in the PFD group
ut only 8% of patients in the STO group showed
ormalization of transit time following successful treat-
ent of pelvic floor dyssynergia, suggesting that delayed
ransit in the PFD group was secondary to pelvic floor
yssynergia rather than being due to a primary colon
otility disorder.
Table 1 shows changes in anorectal parameters from
aseline to follow-up for the PFD group and the STO
roup separately. Consistent with the correlations in the
ooled sample, both the PFD group and the STO group
howed reductions in dyssynergia and increases in rectal
ressure during straining, which were the intended ef-
ects of biofeedback. Both groups also showed decreases
n the threshold volume of rectal distention required to
licit an urge to defecate, and the PFD group showed a
ignificant reduction in maximum tolerable volume.
hese changes in sensory thresholds were unanticipated
nd are believed to reflect the effects of eliminating or
educing the chronic distention of the rectum with re-
ained stool.
Predictors of Outcome From Biofeedback
Training
Importantly, a group of physiologic variables that
dentify patients who have pelvic floor dyssynergia pre-
icted the response to biofeedback training. These vari-
bles were dyssynergia on manometry, inability to defe-
ate a water-filled balloon, and rectal stasis (retention of
tool in the rectum). This supports the hypothesis that
iofeedback training to teach relaxation of the pelvic
oor only benefits those patients who have an objectively
easurable dysfunction of the pelvic floor. A second
roup of variables that were correlated with the outcome
f biofeedback training appear to identify patients who
ad more severe constipation; they did more poorly.
hese variables included a greater number of retained
itzmarks during the transit study and fewer bowel
ovements and more frequent use of laxatives during
aseline. Interestingly, frequency of reporting straining
o defecate did not predict response to pelvic floor
iofeedback.
Frequency of experiencing abdominal pain predicted a
oor response to biofeedback. This was an unexpected
nding and is unexplained. It may reflect patients whoave irritable bowel syndrome in addition to chronic
onstipation.
Study Limitations
The effectiveness of pelvic floor biofeedback train-
ng depends in part on the skills of the biofeedback
herapist and the particular techniques used to perform
he training. The biofeedback training procedures used
n this study are representative of what has been de-
cribed in the literature, but they differ from the tech-
iques used by some laboratories. Moreover, all patients
ere treated by one physician who is highly experienced
n biofeedback training. It is unknown whether similarly
ood outcomes will be obtained in other research or
linical settings. Nevertheless, these study findings show
hat substantial clinical benefits can be achieved in suit-
bly selected patients and that they can be maintained for
t least 2 years.
Specificity of Biofeedback Training Effects
Norton et al29 recently reported the results of a
tudy comparing biofeedback with standard care and
dvice for the treatment of fecal incontinence. They
ound no differences in patients’ ratings of their satisfac-
ion with treatment and no differences in the frequency
f incontinence following treatment. Anal canal squeeze
ressure and anal canal resting pressure improved in all
atients, but improvement was not related to whether
he patients received biofeedback training. These inves-
igators concluded that biofeedback provides no greater
enefit than standard care supplemented by advice and
ducation. Our data suggest that, for outlet dysfunction
onstipation at least, biofeedback does provide a specific
enefit. First, 71% of patients with outlet dysfunction–
ype constipation reported that they were somewhat or
reatly improved, and improvement ratings were sub-
tantiated by increases in the frequency of bowel move-
ents and decreases in laxative use and straining. Sec-
nd, improvement was related to the etiology of the
omplaint of constipation; only patients with pelvic floor
yssynergia and inability to defecate a water-filled bal-
oon benefited, and benefits were strongly correlated with
mprovement in the ability to relax the pelvic floor
uring defecation and improvement in the ability to
efecate a water-filled balloon. Third, improvements
ere well sustained for the 2 years that these patients
ere followed up after treatment.
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